82 related articles for article (PubMed ID: 3075884)
21. [Possible significance of free oxygen radicals for reperfusion injury].
Becker BF; Massoudy P; Permanetter B; Raschke P; Zahler S
Z Kardiol; 1993; 82 Suppl 5():49-58. PubMed ID: 8154162
[TBL] [Abstract][Full Text] [Related]
22. Effects of pirfenidone on the generation of reactive oxygen species in vitro.
Giri SN; Leonard S; Shi X; Margolin SB; Vallyathan V
J Environ Pathol Toxicol Oncol; 1999; 18(3):169-77. PubMed ID: 15281229
[TBL] [Abstract][Full Text] [Related]
23. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates.
Chaturvedi V; Wong B; Newman SL
J Immunol; 1996 May; 156(10):3836-40. PubMed ID: 8621921
[TBL] [Abstract][Full Text] [Related]
24. Elevated semicarbazide-sensitive amine oxidase (SSAO) activity in lung with ischemia-reperfusion injury: protective effect of ischemic preconditioning plus SSAO inhibition.
Ucar G; Topaloglu E; Burak Kandilci H; Gumusel B
Life Sci; 2005 Dec; 78(4):421-7. PubMed ID: 16111719
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of Trichophyton quinckeanum and Trichophyton rubrum to products of oxidative metabolism.
Calderon RA; Shennan GI
Immunology; 1987 Jul; 61(3):283-8. PubMed ID: 3610210
[TBL] [Abstract][Full Text] [Related]
26. Erythrocytes protect alpha-1-proteinase inhibitor from oxidative inactivation induced by chemicals, the myeloperoxidase-H2O2-halide system and stimulated polymorphonuclear leukocytes.
Nowak D; Piasecka G
Exp Pathol; 1991; 42(1):47-58. PubMed ID: 1652455
[TBL] [Abstract][Full Text] [Related]
27. What should an ideal antioxidant do (and not do)?
Flenley DC
Bull Eur Physiopathol Respir; 1987; 23(4):279-85. PubMed ID: 2825863
[TBL] [Abstract][Full Text] [Related]
28. [Active oxygen generating system in immune cells].
Kanegasaki S
Rinsho Byori; 1992 Apr; 40(4):392-6. PubMed ID: 1317472
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the protective effects of the antioxidants ascorbate, cysteine, and dapsone on the phagocyte-mediated oxidative inactivation of human alpha-1-protease inhibitor in vitro.
Theron A; Anderson R
Am Rev Respir Dis; 1985 Nov; 132(5):1049-54. PubMed ID: 2998243
[TBL] [Abstract][Full Text] [Related]
30. Anti-oxidant effects of gold compounds.
Miyachi Y; Yoshioka A; Imamura S; Niwa Y
Br J Dermatol; 1987 Jan; 116(1):39-46. PubMed ID: 3028464
[TBL] [Abstract][Full Text] [Related]
31. Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro.
Carp H; Janoff A
J Clin Invest; 1980 Nov; 66(5):987-95. PubMed ID: 6253528
[TBL] [Abstract][Full Text] [Related]
32. The effect of tranilast of the generation of reactive oxygen species.
Miyachi Y; Imamura S; Niwa Y
J Pharmacobiodyn; 1987 Jun; 10(6):255-9. PubMed ID: 2444694
[TBL] [Abstract][Full Text] [Related]
33. Protective role of glutathione on alpha 1 proteinase inhibitor inactivation by the myeloperoxidase system. Hypothetic study for therapeutic strategy in the management of smokers' emphysema.
Gressier B; Lebegue S; Gosset P; Brunet C; Luyckx M; Dine T; Cazin M; Cazin JC; Wallaert B
Fundam Clin Pharmacol; 1994; 8(6):518-24. PubMed ID: 7721228
[TBL] [Abstract][Full Text] [Related]
34. Effect of antibiotics on the generation of reactive oxygen species.
Miyachi Y; Yoshioka A; Imamura S; Niwa Y
J Invest Dermatol; 1986 Apr; 86(4):449-53. PubMed ID: 3755739
[TBL] [Abstract][Full Text] [Related]
35. Different selectivities of oxidants during oxidation of methionine residues in the alpha-1-proteinase inhibitor.
Maier KL; Matejkova E; Hinze H; Leuschel L; Weber H; Beck-Speier I
FEBS Lett; 1989 Jul; 250(2):221-6. PubMed ID: 2546797
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the antioxidant properties of HYAFF-11p75, AQUACEL and hyaluronan towards reactive oxygen species in vitro.
Moseley R; Leaver M; Walker M; Waddington RJ; Parsons D; Chen WY; Embery G
Biomaterials; 2002 May; 23(10):2255-64. PubMed ID: 11962667
[TBL] [Abstract][Full Text] [Related]
37. Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils.
Clark RA; Stone PJ; El Hag A; Calore JD; Franzblau C
J Biol Chem; 1981 Apr; 256(7):3348-53. PubMed ID: 6162845
[TBL] [Abstract][Full Text] [Related]
38. [Pulmonary emphysema--the etiology and therapy].
Kawakami Y
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1679-89. PubMed ID: 10581746
[No Abstract] [Full Text] [Related]
39. Leukocyte-mediated inactivation of alpha 1-proteinase inhibitor is inhibited by amino analogues of alpha-tocopherol.
Bolkenius FN
Biochim Biophys Acta; 1991 Oct; 1095(1):23-9. PubMed ID: 1657188
[TBL] [Abstract][Full Text] [Related]
40. [Chemical basis of nonspecific immunity].
Muraviev RA; Rogovin VV
Izv Akad Nauk Ser Biol; 2001; (3):284-92. PubMed ID: 11433938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
